Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 13/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.74 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.74 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.74 |
| ▸ | CCR2 | P41597 | 1/20 | 0.74 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.74 |
| ▸ | BLM | P54132 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.74 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.53 |
| ▸ | KDM5C | P41229 | 1/20 | 0.49 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2489671 | 0.99 | CXCR4 (0.75) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL5962418 | 0.93 | CXCR4 (0.66) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL10006951 | 0.93 | CXCR4 (0.63) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL13995932 | 0.93 | SIGMAR1 (0.61) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL1160126 | 0.91 | SIGMAR1 (0.62) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL10901935 | 0.90 | SIGMAR1 (0.61) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Hydrochloric Acid SCHEMBL28273325 | 0.90 | SIGMAR1 (0.61) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Edetic Acid SCHEMBL2365124 | 0.89 | CXCR4 (0.59) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL3894421 | 0.87 | CXCR4 (0.72) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL5611617 | 0.86 | CXCR4 (1.00) | CXCR4MEN1CHRM2CHRM1ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121330728-B | Pulmonary embolism focus segmentation method, system and storage medium based on image recognition | 郑州大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260058021-A1 | SYSTEM AND METHOD FOR PULMONARY EMBOLISM DETECTION FROM THE ELECTROCARDIOGRAM USING DEEP LEARNING | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-02-26 | — | — | US | claimed |
| EP-4332227-B1 | RNA CONTAINING MODIFIED NUCLEOSIDES AND METHODS OF USE THEREOF | UNIV PENNSYLVANIA (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | UNIV MUENCHEN TECH (DE) | 2026-01-22 | — | — | US | claimed |
| US-12424327-B2 | System and method for pulmonary embolism detection from the electrocardiogram using deep learning | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2025-09-23 | — | — | US | claimed |
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GMBH (NL) | 2025-09-23 | — | — | US | claimed |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2025-09-18 | — | — | US | claimed |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | Technische Universität München (DE) | 2025-08-19 | — | — | US | claimed |
| EP-4599852-A2 | RNA CONTAINING MODIFIED NUCLEOSIDES AND METHODS OF USE THEREOF | The Trustees of the University of Pennsylvania (US) | 2025-08-13 | — | — | EP | claimed |
| CN-120147449-A | Method for synthesizing CT angiography image based on generation countermeasure network algorithm | 中国人民解放军总医院第一医学中心 | 2025-06-13 | — | — | CN | claimed |
| CN-114783558-A | CTPA image report generation system for pulmonary embolism patients | 四川大学华西医院 | 2022-07-22 | — | — | CN | claimed |
| US-11389547-B2 | RNA containing modified nucleosides and methods of use thereof | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-07-19 | — | — | US | claimed |
| US-20220118120-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2022-04-21 | — | — | US | claimed |
| CN-114245807-A | FLT3L-FC fusion proteins and methods of use | 吉利德科学公司 | 2022-03-25 | — | — | CN | claimed |
| EP-3917582-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2021-12-08 | — | — | EP | claimed |
| CN-113573743-A | Diagnostic imaging agents for cancer | 慕尼黑工业大学 | 2021-10-29 | — | — | CN | claimed |
| CN-107106709-B | Radiopharmaceutical conjugates comprising a metabolite and an EPR agent targeting tumor cells | 南非核能源有限公司 | 2021-04-06 | — | — | CN | claimed |
| WO-2020157184-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2020-08-06 | — | — | WO | claimed |
| US-20200197545-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | TECHNISCHE UNIVERSITÄT MÜNCHEN - KLINIKUM RECHTS DER ISAR (DE) | 2020-06-25 | — | — | US | claimed |
| US-20070184537-A1 | Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides | PAUL SCHERRER INSTITUT (CH) | 2007-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | HNRNPF, ANXA3, SLC67A1 | CXCR4 2617/4885MEN1 582/4885CHRM2 4081/4885 |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | FOLH1, SLC19A1, KLK3 | CXCR4 1554/4885MEN1 182/4885CHRM2 953/4885 |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | CXCR4, CXCR1, CXCR3 | CXCR4 1/4885MEN1 2192/4885CHRM2 882/4885 |
| US-20200197545-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | SSTR2, SSTR1, PAICS | CXCR4 1133/4885MEN1 193/4885CHRM2 2694/4885 |
| US-20260058021-A1 | SYSTEM AND METHOD FOR PULMONARY EMBOLISM DETECTION FROM THE ELECTROCARDIOGRAM USING DEEP LEARNING | F2, PLG, PLAT | CXCR4 3765/4885MEN1 4032/4885CHRM2 1525/4885 |
| US-20070184537-A1 | Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides | EPRS1, SLC7A11, QPCTL | CXCR4 3859/4885MEN1 1331/4885CHRM2 4370/4885 |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | PAICS, SSTR2, SSTR1 | CXCR4 1144/4885MEN1 193/4885CHRM2 2679/4885 |
| US-20220118120-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | FOLH1, FOLR1, KLK3 | CXCR4 3616/4885MEN1 177/4885CHRM2 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.